Accumulating evidences support the importance of RNA biology in the hallmarks of cancer. Post-transcriptional steps of gene expression (pre-mRNA splicing and polyadenylation, mRNA stability, translation and modifications) as well as the functions of non-coding RNAs are increasingly diverse. It is therefore challenging to comprehend this complexity in the context of cancer.
The internationally renowned experts invited to this symposium will present the recent advances in our understanding of RNA biology in cancer. This will be complemented by at least 10 selected talks and 60 poster presentations.
The symposium is intended to bring together RNA and cancer biologists. It is expected that the small size of the attendance (max 120) will foster stimulating discussions that will lead to innovative collaborations.